Loading the map…
Research and experimental development on biotechnology · Stevenage, Hertfordshire
Target to Treatment (TTT) Consulting
Target to Treatment (TTT) Consulting Limited
Private limited company registered in Stevenage, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Feb 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
3 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021 | 2022 | 2023* | 2024 | 2025 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current assets | ||||
| of which debtors | ||||
| of which cash | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Net assets | ||||
| Ratios | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Cash ratioCash for every £1 owed within a year | ||||
6 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-11-02
- AccountsTotal exemption full accounts made up to 28 February 2025
- DirectorsTermination of appointment of David Charles Lukey as a director on 29 November 2024
- AccountsTotal exemption full accounts made up to 29 February 2024
- AccountsTotal exemption full accounts made up to 28 February 2023
- AccountsTotal exemption full accounts made up to 28 February 2022
- DirectorsTermination of appointment of David Lukey as a secretary on 13 February 2022
- AccountsTotal exemption full accounts made up to 28 February 2021
- NoticeAdministrative restoration application
- NoticeFinal Gazette dissolved via compulsory strike-off
- NoticeFirst Gazette notice for compulsory strike-off
- AccountsTotal exemption full accounts made up to 29 February 2020
- AccountsTotal exemption full accounts made up to 28 February 2019
3 earlier
- AccountsTotal exemption full accounts made up to 28 February 2018
- AccountsTotal exemption full accounts made up to 28 February 2017
- IncorporationIncorporation
- Accounts
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Target to Treatment (TTT) Consulting do?
Private limited company registered in Stevenage, classed under “Research and experimental development on biotechnology”.
›How much turnover does Target to Treatment (TTT) Consulting make?
Answered in the full report
›Is Target to Treatment (TTT) Consulting profitable?
Target to Treatment (TTT) Consulting's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Target to Treatment (TTT) Consulting?
Answered in the full report
›Who runs and owns Target to Treatment (TTT) Consulting?
Its directors are Pauline Teresa Lukey. Its owners are shown to subscribers.
›Where is Target to Treatment (TTT) Consulting based?
Its registered office is Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2FX, in Stevenage, Hertfordshire.
›When was Target to Treatment (TTT) Consulting founded?
Target to Treatment (TTT) Consulting Limited was incorporated on 24 February 2016.
›Is Target to Treatment (TTT) Consulting still trading?
The register lists Target to Treatment (TTT) Consulting Limited as active.